Marie-Odile Habert, MD-PhD

Marie-Odile Habert became a medical doctor in 1984, got a qualification in Nuclear Medicine in 1986 and master degrees in Biophysics and Medical Imaging between 1990 and 1996.

She is now a nuclear medicine physician at Pitié-Salpêtrière Hospital, senior lecturer in biophysics at Sorbonne Université, and affiliated to the LIB research lab (Laboratoire d’Imagerie Biomédicale, Biomedical Imaging Laboratory). Since 2015 she is also a scientific coordinator for PET/MR research at the ICM (Institut du Cerveau et de la Moelle épinière, Brain and Spine Institute). She has been an elected member of the Administration Counsel of Sorbonne Université since 2017 and of the National Universities Council since 2010.

With 30 years of experience, Dr. Habert is a specialist in nuclear neurology, brain SPECT and PET. Particularly interested in neurodegenerative diseases and epilepsy, she is responsible for the PET, SPECT, SPECT/MR sides of clinical studies and therapeutic trials focusing on imaging biomarkers of Alzheimer’s disease, Parkinson, LSA or frontotemporal dementia. Often multicentric, these studies allowed her to accumulate a strong knowledge of large imaging cohorts and related challenges.

In this context, her main goal while working with the CATI since its creation in 2012 is to offer her expertise in Nuclear Medecine image processing and analysis and also to improve the harmonization of multicentric PET/SPECT acquisitions. She is the co-director of the CATI since 2017.

Publications :

Habert MO, Bertin H, Labit M, Diallo M, Marie S, Martineau K, Kas A, Causse-Lemercier V, Bakardjian H, Epelbaum S, Chételat G, Houot M, Hampel H, Dubois B, Mangin JF, Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds, Ann Nucl Med, 2018, 32 (2) , pp. 75-86

Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P, Stephens A, Guedj E, Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study, Alzheimers Dement, 2017, S1552-5260 (17) , pp. 33763-9

Teipel SJ, Cavedo E, Weschke S, Grothe MJ, Rojkova K, Fontaine G, Dauphinot L, Gonzalez-Escamilla G, Potier MC, Bertin H, Habert MO, Dubois B, Hampel H, Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints, Neurobiol Aging, 2017, 57 , pp. 143-52

Di Stefano F, Kas A, Habert MO, Decazes P, Lamari F, Lista S, Hampel H, Teichmann M, The phenotypical core of Alzheimer-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study, Alzheimers Dement, 2016, 12 (7) , pp. 786-95

Habert MO, Marie S, Bertin H, Reynal M, Martini JB, Diallo M, Kas A, Trébossen R, Optimization of brain PET imaging for a multicentre trial: the French CATI experience, EJNMMI Phys, 2016, 3 (1) , pp. 6

Operto G, Chupin M, Batrancourt B, Habert MO, Colliot O, Benali H, Poupon C, Champseix C, Delmaire C, Marie S, Rivière D, Pélégrini-Issac M, Perlbarg V, Trébossen R, Bottlaender M, Frouin V, Grigis A, Orfanos DP, Dary H, Fillon L, Azouani C, Bouyahia A, Fischer C, Edward L, Bouin M, Thoprakarn U, Li J, Makkaoui L, Poret S, Dufouil C, CATI: A large distributed infrastructure for the neuroimaging of cohorts, Neuroinformatics, 2016, 14 (3) , pp. 253-64

Lagarde J, Hamelin L, Hahn V, Habert MO, Seilhean D, Duyckaerts C, Sarazin M, Progressive supranuclear palsy syndrome and semantic dementia in neuropathologically proven Lewy body disease: A report of two cases, J Alzheimers Dis, 2015, 47 (1) , pp. 95-101

Bertoux M, Volle E, de Souza LC, Funkiewiez A, Dubois B, Habert MO, Neural correlates of the mini-SEA (Social cognition and Emotional Assessment) in behavioral variant frontotemporal dementia, Brain Imaging Behav, 2014, 8 (1) , pp. 1-6

Habert MO, Béra G, Yeni N, Kas A, [Interest and role of brain scintigraphy in the diagnosis of dementia in 2014] (in French), Geriatr Psychol Neuropsychiatr Vieil, 2014, 12 (4) , pp. 413-23
Kas A, Lavault S, Habert MO, Arnulf I, Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome, Brain, 2014, 137 (Pt 7) , pp. 2077-87

Toussaint PJ, Maiz S, Coynel D, Doyon J, Messé A, Cruz De Souza L, Sarazin M, Perlbarg V, Habert MO, Benali H, Characteristics of the default mode functional connectivity in normal ageing and Alzheimer’s disease using resting state fMRI with a combined approach of entropy-based and graph theoretical measurements, Neuroimage, 2014, 101 , pp. 778-86

Habert MO, Kas A, Aspects techniques et pratiques, et indications de la tomographie d’émission monophotonique cérébrale, EMC – Neurologie, 2013, 10 (3) , pp. 1-17